메뉴 건너뛰기




Volumn 5, Issue 10, 2014, Pages 2947-2961

Dual aurora a and jak2 kinase blockade effectively suppresses malignant transformation

Author keywords

[No Author keywords available]

Indexed keywords

AJI 100; AJI 214; ALISERTIB; ANTINEOPLASTIC AGENT; AURORA A KINASE; CASPASE 3; HISTONE H3; JANUS KINASE 2; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; RUXOLITINIB; STAT3 PROTEIN; TOZASERTIB; UNCLASSIFIED DRUG; AURKA PROTEIN, HUMAN; JAK2 PROTEIN, HUMAN; PROTEIN KINASE INHIBITOR; SMALL INTERFERING RNA;

EID: 84902117775     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1615     Document Type: Article
Times cited : (18)

References (54)
  • 1
    • 77953569296 scopus 로고    scopus 로고
    • Centromere localization of INCENP-Aurora B is sufficient to support spindle checkpoint function
    • Becker M, Stolz A, Ertych N and Bastians H. Centromere localization of INCENP-Aurora B is sufficient to support spindle checkpoint function. Cell Cycle. 2010; 9(7):1360-1372.
    • (2010) Cell Cycle , vol.9 , Issue.7 , pp. 1360-1372
    • Becker, M.1    Stolz, A.2    Ertych, N.3    Bastians, H.4
  • 2
    • 79951778220 scopus 로고    scopus 로고
    • Two TPX2-dependent switches control the activity of Aurora A
    • Xu X, Wang X, Xiao Z, Li Y and Wang Y. Two TPX2-dependent switches control the activity of Aurora A. PLoS One. 2011; 6(2):e16757.
    • (2011) PLoS One , vol.6 , Issue.2
    • Xu, X.1    Wang, X.2    Xiao, Z.3    Li, Y.4    Wang, Y.5
  • 3
    • 84871880725 scopus 로고    scopus 로고
    • Studying the roles of Aurora-C kinase during meiosis in mouse oocytes
    • Yang KT, Lin YN, Li SK and Tang TK. Studying the roles of Aurora-C kinase during meiosis in mouse oocytes. Methods Mol Biol. 2013; 957:189-202.
    • (2013) Methods Mol Biol , vol.957 , pp. 189-202
    • Yang, K.T.1    Lin, Y.N.2    Li, S.K.3    Tang, T.K.4
  • 5
    • 0030962953 scopus 로고    scopus 로고
    • A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines
    • Sen S, Zhou H and White RA. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene. 1997; 14(18):2195-2200.
    • (1997) Oncogene , vol.14 , Issue.18 , pp. 2195-2200
    • Sen, S.1    Zhou, H.2    White, R.A.3
  • 6
    • 18044391525 scopus 로고    scopus 로고
    • Aurora kinases, aneuploidy and cancer, a coincidence or a real link?
    • Giet R, Petretti C and Prigent C. Aurora kinases, aneuploidy and cancer, a coincidence or a real link? Trends Cell Biol. 2005; 15(5):241-250.
    • (2005) Trends Cell Biol , vol.15 , Issue.5 , pp. 241-250
    • Giet, R.1    Petretti, C.2    Prigent, C.3
  • 7
    • 0038341158 scopus 로고    scopus 로고
    • The Aurora kinases: role in cell transformation and tumorigenesis
    • Katayama H, Brinkley WR and Sen S. The Aurora kinases: role in cell transformation and tumorigenesis. Cancer Metastasis Rev. 2003; 22(4):451-464.
    • (2003) Cancer Metastasis Rev , vol.22 , Issue.4 , pp. 451-464
    • Katayama, H.1    Brinkley, W.R.2    Sen, S.3
  • 9
    • 1642556824 scopus 로고    scopus 로고
    • Aurora-A kinase regulates telomerase activity through c-Myc in human ovarian and breast epithelial cells
    • Yang H, Ou CC, Feldman RI, Nicosia SV, Kruk PA and Cheng JQ. Aurora-A kinase regulates telomerase activity through c-Myc in human ovarian and breast epithelial cells. Cancer Res. 2004; 64(2):463-467.
    • (2004) Cancer Res , vol.64 , Issue.2 , pp. 463-467
    • Yang, H.1    Ou, C.C.2    Feldman, R.I.3    Nicosia, S.V.4    Kruk, P.A.5    Cheng, J.Q.6
  • 12
    • 0038746733 scopus 로고    scopus 로고
    • The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint
    • Hauf S, Cole RW, LaTerra S, Zimmer C, Schnapp G, Walter R, Heckel A, van Meel J, Rieder CL and Peters JM. The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint. J Cell Biol. 2003; 161(2):281-294.
    • (2003) J Cell Biol , vol.161 , Issue.2 , pp. 281-294
    • Hauf, S.1    Cole, R.W.2    Laterra, S.3    Zimmer, C.4    Schnapp, G.5    Walter, R.6    Heckel, A.7    van Meel, J.8    Rieder, C.L.9    Peters, J.M.10
  • 15
    • 79952209771 scopus 로고    scopus 로고
    • Update on Aurora Kinase Targeted Therapeutics in Oncology
    • Green MR, Woolery JE and Mahadevan D. Update on Aurora Kinase Targeted Therapeutics in Oncology. Expert Opin Drug Discov. 2011; 6(3):291-307.
    • (2011) Expert Opin Drug Discov , vol.6 , Issue.3 , pp. 291-307
    • Green, M.R.1    Woolery, J.E.2    Mahadevan, D.3
  • 20
    • 79952565110 scopus 로고    scopus 로고
    • Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell lymphoma
    • Qi W, Cooke LS, Liu X, Rimsza L, Roe DJ, Manziolli A, Persky DO, Miller TP and Mahadevan D. Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell lymphoma. Biochem Pharmacol. 2011; 81(7):881-890.
    • (2011) Biochem Pharmacol , vol.81 , Issue.7 , pp. 881-890
    • Qi, W.1    Cooke, L.S.2    Liu, X.3    Rimsza, L.4    Roe, D.J.5    Manziolli, A.6    Persky, D.O.7    Miller, T.P.8    Mahadevan, D.9
  • 21
    • 84873094495 scopus 로고    scopus 로고
    • Additive effects of vorinostat and MLN8237 in pediatric leukemia, medulloblastoma, and neuroblastoma cell lines
    • Muscal JA, Scorsone KA, Zhang L, Ecsedy JA and Berg SL. Additive effects of vorinostat and MLN8237 in pediatric leukemia, medulloblastoma, and neuroblastoma cell lines. Invest New Drugs. 2013; 31(1):39-45.
    • (2013) Invest New Drugs , vol.31 , Issue.1 , pp. 39-45
    • Muscal, J.A.1    Scorsone, K.A.2    Zhang, L.3    Ecsedy, J.A.4    Berg, S.L.5
  • 22
    • 79957528550 scopus 로고    scopus 로고
    • The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib
    • Kelly KR, Ecsedy J, Medina E, Mahalingam D, Padmanabhan S, Nawrocki ST, Giles FJ and Carew JS. The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib. J Cell Mol Med. 2011; 15(10):2057-2070.
    • (2011) J Cell Mol Med , vol.15 , Issue.10 , pp. 2057-2070
    • Kelly, K.R.1    Ecsedy, J.2    Medina, E.3    Mahalingam, D.4    Padmanabhan, S.5    Nawrocki, S.T.6    Giles, F.J.7    Carew, J.S.8
  • 23
    • 52949089050 scopus 로고    scopus 로고
    • JAKs in pathology: role of Janus kinases in hematopoietic malignancies and immunodeficiencies
    • Vainchenker W, Dusa A and Constantinescu SN. JAKs in pathology: role of Janus kinases in hematopoietic malignancies and immunodeficiencies. Semin Cell Dev Biol. 2008; 19(4):385-393.
    • (2008) Semin Cell Dev Biol , vol.19 , Issue.4 , pp. 385-393
    • Vainchenker, W.1    Dusa, A.2    Constantinescu, S.N.3
  • 25
    • 1042302005 scopus 로고    scopus 로고
    • The STATs of cancer-new molecular targets come of age
    • Yu H and Jove R. The STATs of cancer-new molecular targets come of age. Nat Rev Cancer. 2004; 4(2):97-105.
    • (2004) Nat Rev Cancer , vol.4 , Issue.2 , pp. 97-105
    • Yu, H.1    Jove, R.2
  • 26
    • 0036093058 scopus 로고    scopus 로고
    • Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival
    • Benekli M, Xia Z, Donohue KA, Ford LA, Pixley LA, Baer MR, Baumann H and Wetzler M. Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival. Blood. 2002; 99(1):252-257.
    • (2002) Blood , vol.99 , Issue.1 , pp. 252-257
    • Benekli, M.1    Xia, Z.2    Donohue, K.A.3    Ford, L.A.4    Pixley, L.A.5    Baer, M.R.6    Baumann, H.7    Wetzler, M.8
  • 27
    • 84875378326 scopus 로고    scopus 로고
    • The role of Janus kinase 2 (JAK2) in myeloproliferative neoplasms: therapeutic implications
    • Quintas-Cardama A. The role of Janus kinase 2 (JAK2) in myeloproliferative neoplasms: therapeutic implications. Leuk Res. 2013; 37(4):465-472.
    • (2013) Leuk Res , vol.37 , Issue.4 , pp. 465-472
    • Quintas-Cardama, A.1
  • 31
    • 10344236486 scopus 로고    scopus 로고
    • Aurora-kinase inhibitors as anticancer agents
    • Keen N and Taylor S. Aurora-kinase inhibitors as anticancer agents. Nat Rev Cancer. 2004; 4(12):927-936.
    • (2004) Nat Rev Cancer , vol.4 , Issue.12 , pp. 927-936
    • Keen, N.1    Taylor, S.2
  • 34
    • 79956035239 scopus 로고    scopus 로고
    • Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapy
    • Rao B vLI, Higgins M, Campbel J, Thompson AM, Lane DP, Lain S. Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapy. Oncotarget. 2010; No;1(7):639-650.
    • (2010) Oncotarget , vol.1 , Issue.7 , pp. 639-650
    • Rao, B.1    van Leeuwen, I.M.2    Higgins, M.3    Campbel, J.4    Thompson, A.M.5    Lane, D.P.6    Lain, S.7
  • 35
    • 26244463218 scopus 로고    scopus 로고
    • Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling inducesapoptosis and cell cycle arrest of colon carcinoma cells
    • Lin Q, Lai R, Chirieac LR, Li C, Thomazy VA, Grammatikakis I, Rassidakis GZ, Zhang W, Fujio Y, Kunisada K, Hamilton SR and Amin HM. Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling inducesapoptosis and cell cycle arrest of colon carcinoma cells. Am J Pathol. 2005; 167(4):969-980.
    • (2005) Am J Pathol , vol.167 , Issue.4 , pp. 969-980
    • Lin, Q.1    Lai, R.2    Chirieac, L.R.3    Li, C.4    Thomazy, V.A.5    Grammatikakis, I.6    Rassidakis, G.Z.7    Zhang, W.8    Fujio, Y.9    Kunisada, K.10    Hamilton, S.R.11    Amin, H.M.12
  • 36
    • 80555154949 scopus 로고    scopus 로고
    • Myeloproliferative neoplasms: from JAK2 mutations discovery to JAK2 inhibitor therapies
    • Jun 2
    • Passamonti F MM, Caramazza D, Cazzola M. Myeloproliferative neoplasms: from JAK2 mutations discovery to JAK2 inhibitor therapies. Oncotarget. 2011; Jun2;(6):485-490.
    • (2011) Oncotarget , Issue.6 , pp. 485-490
    • Passamonti, F.M.M.1    Caramazza, D.2    Cazzola, M.3
  • 37
    • 53349101074 scopus 로고    scopus 로고
    • Inhibition of Aurora-A suppresses epithelial-mesenchymal transition and invasion by downregulating MAPK in nasopharyngeal carcinoma cells
    • Wan XB, Long ZJ, Yan M, Xu J, Xia LP, Liu L, Zhao Y, Huang XF, Wang XR, Zhu XF, Hong MH and Liu Q. Inhibition of Aurora-A suppresses epithelial-mesenchymal transition and invasion by downregulating MAPK in nasopharyngeal carcinoma cells. Carcinogenesis. 2008; 29(10):1930-1937.
    • (2008) Carcinogenesis , vol.29 , Issue.10 , pp. 1930-1937
    • Wan, X.B.1    Long, Z.J.2    Yan, M.3    Xu, J.4    Xia, L.P.5    Liu, L.6    Zhao, Y.7    Huang, X.F.8    Wang, X.R.9    Zhu, X.F.10    Hong, M.H.11    Liu, Q.12
  • 38
    • 40049093105 scopus 로고    scopus 로고
    • Inhibition of signal transducer and activator of transcription 3 expression by RNA interference suppresses invasion through inducing anoikis in human colon cancer cells
    • Fan Y, Zhang YL, Wu Y, Zhang W, Wang YH, Cheng ZM and Li H. Inhibition of signal transducer and activator of transcription 3 expression by RNA interference suppresses invasion through inducing anoikis in human colon cancer cells. World J Gastroenterol. 2008; 14(3):428-434.
    • (2008) World J Gastroenterol , vol.14 , Issue.3 , pp. 428-434
    • Fan, Y.1    Zhang, Y.L.2    Wu, Y.3    Zhang, W.4    Wang, Y.H.5    Cheng, Z.M.6    Li, H.7
  • 39
    • 1842836011 scopus 로고    scopus 로고
    • Src family kinase activity is required for signal tranducer and activator of transcription 3 and focal adhesion kinase phosphorylation and vascular endothelial growth factor signaling in vivo and for anchorage-dependent and-independent growth of human tumor cells
    • Laird AD, Li G, Moss KG, Blake RA, Broome MA, Cherrington JM and Mendel DB. Src family kinase activity is required for signal tranducer and activator of transcription 3 and focal adhesion kinase phosphorylation and vascular endothelial growth factor signaling in vivo and for anchorage-dependent and-independent growth of human tumor cells. Mol Cancer Ther. 2003; 2(5):461-469.
    • (2003) Mol Cancer Ther , vol.2 , Issue.5 , pp. 461-469
    • Laird, A.D.1    Li, G.2    Moss, K.G.3    Blake, R.A.4    Broome, M.A.5    Cherrington, J.M.6    Mendel, D.B.7
  • 40
    • 77950915903 scopus 로고    scopus 로고
    • The current status and the future of JAK2 inhibitors for the treatment of myeloproliferative diseases
    • Hitoshi Y, Lin N, Payan DG and Markovtsov V. The current status and the future of JAK2 inhibitors for the treatment of myeloproliferative diseases. Int J Hematol. 2010; 91(2):189-200.
    • (2010) Int J Hematol , vol.91 , Issue.2 , pp. 189-200
    • Hitoshi, Y.1    Lin, N.2    Payan, D.G.3    Markovtsov, V.4
  • 41
    • 84865681647 scopus 로고    scopus 로고
    • Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or-refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinoma
    • Matulonis UA, Sharma S, Ghamande S, Gordon MS, Del Prete SA, Ray-Coquard I, Kutarska E, Liu H, Fingert H, Zhou X, Danaee H and Schilder RJ. Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or-refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinoma. Gynecol Oncol. 2012; 127(1):63-69.
    • (2012) Gynecol Oncol , vol.127 , Issue.1 , pp. 63-69
    • Matulonis, U.A.1    Sharma, S.2    Ghamande, S.3    Gordon, M.S.4    Del Prete, S.A.5    Ray-Coquard, I.6    Kutarska, E.7    Liu, H.8    Fingert, H.9    Zhou, X.10    Danaee, H.11    Schilder, R.J.12
  • 42
    • 84875373630 scopus 로고    scopus 로고
    • Alisertib (MLN8237) an investigational agent suppresses Aurora A and B activity, inhibits proliferation, promotes endo-reduplication and induces apoptosis in T-NHL cell lines supporting its importance in PTCL treatment
    • Qi W, Spier C, Liu X, Agarwal A, Cooke LS, Persky DO, Chen D, Miller TP and Mahadevan D. Alisertib (MLN8237) an investigational agent suppresses Aurora A and B activity, inhibits proliferation, promotes endo-reduplication and induces apoptosis in T-NHL cell lines supporting its importance in PTCL treatment. Leuk Res. 2013; 37(4):434-439.
    • (2013) Leuk Res , vol.37 , Issue.4 , pp. 434-439
    • Qi, W.1    Spier, C.2    Liu, X.3    Agarwal, A.4    Cooke, L.S.5    Persky, D.O.6    Chen, D.7    Miller, T.P.8    Mahadevan, D.9
  • 46
    • 3843142735 scopus 로고    scopus 로고
    • In vitro studies of a FLT3 inhibitor combined with chemotherapy: sequence of administration is important to achieve synergistic cytotoxic effects
    • Levis M, Pham R, Smith BD and Small D. In vitro studies of a FLT3 inhibitor combined with chemotherapy: sequence of administration is important to achieve synergistic cytotoxic effects. Blood. 2004; 104(4):1145-1150.
    • (2004) Blood , vol.104 , Issue.4 , pp. 1145-1150
    • Levis, M.1    Pham, R.2    Smith, B.D.3    Small, D.4
  • 48
    • 77949535491 scopus 로고    scopus 로고
    • Phase 2 study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis
    • Santos FP, Kantarjian HM, Jain N, Manshouri T, Thomas DA, Garcia-Manero G, Kennedy D, Estrov Z, Cortes J and Verstovsek S. Phase 2 study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis. Blood. 2010; 115(6):1131-1136.
    • (2010) Blood , vol.115 , Issue.6 , pp. 1131-1136
    • Santos, F.P.1    Kantarjian, H.M.2    Jain, N.3    Manshouri, T.4    Thomas, D.A.5    Garcia-Manero, G.6    Kennedy, D.7    Estrov, Z.8    Cortes, J.9    Verstovsek, S.10
  • 50
    • 33947199328 scopus 로고    scopus 로고
    • K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling
    • Campbell PM, Groehler AL, Lee KM, Ouellette MM, Khazak V and Der CJ. K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling. Cancer Res. 2007; 67(5):2098-2106.
    • (2007) Cancer Res , vol.67 , Issue.5 , pp. 2098-2106
    • Campbell, P.M.1    Groehler, A.L.2    Lee, K.M.3    Ouellette, M.M.4    Khazak, V.5    Der, C.J.6
  • 52
    • 0033967589 scopus 로고    scopus 로고
    • Enrichment for submitotic cell populations using flow cytometry
    • Widrow RJ and Laird CD. Enrichment for submitotic cell populations using flow cytometry. Cytometry. 2000; 39(2):126-130.
    • (2000) Cytometry , vol.39 , Issue.2 , pp. 126-130
    • Widrow, R.J.1    Laird, C.D.2
  • 53
    • 79955504184 scopus 로고    scopus 로고
    • Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic mice
    • Balasis ME, Forinash KD, Chen YA, Fulp WJ, Coppola D, Hamilton AD, Cheng JQ and Sebti SM. Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic mice. Clin Cancer Res. 2011; 17(9):2852-2862.
    • (2011) Clin Cancer Res , vol.17 , Issue.9 , pp. 2852-2862
    • Balasis, M.E.1    Forinash, K.D.2    Chen, Y.A.3    Fulp, W.J.4    Coppola, D.5    Hamilton, A.D.6    Cheng, J.Q.7    Sebti, S.M.8
  • 54
    • 84867120378 scopus 로고    scopus 로고
    • RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer
    • Patel RA, Forinash KD, Pireddu R, Sun Y, Sun N, Martin MP, Schonbrunn E, Lawrence NJ and Sebti SM. RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer. Cancer Res. 2012; 72(19):5025-5034.
    • (2012) Cancer Res , vol.72 , Issue.19 , pp. 5025-5034
    • Patel, R.A.1    Forinash, K.D.2    Pireddu, R.3    Sun, Y.4    Sun, N.5    Martin, M.P.6    Schonbrunn, E.7    Lawrence, N.J.8    Sebti, S.M.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.